| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +33% |
| 3Y CAGR | +21% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +42% |
| 3Y CAGR | +28% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,794.20 -34.90 (0.72%) | 22,087.92 | 30.04 | 5.26 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,541.60 +19.60 (0.78%) | 19,159.13 | 28.26 | 5.34 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,674.00 +33.50 (0.44%) | 19,072.13 | 112.44 | 21.85 | ||
Natco PharmaNATCOPHARM | ₹890.20 +0.40 (0.04%) | 15,935.41 | 13.92 | 1.73 |